Moderna’s RSV Vaccine Gets FDA Nod for Younger Adults!

Exciting news for younger adults at risk from RSV! The Food and Drug Administration (FDA) has expanded approval of Moderna’s RSV vaccine to include individuals aged 18 to 59. This…

Moderna’s New COVID Vaccine: A Placebo-Controlled Trial is Coming

Concerns surrounding the FDA’s approval of Moderna’s new mRNA COVID-19 vaccine, mNEXSPIKE, for high-risk individuals have prompted a significant development. Health Secretary Robert F. Kennedy Jr. recently announced that Moderna…